174 related articles for article (PubMed ID: 33980033)
1. Effect of botulinum toxin on quality of life of patients with chronic myofascial pain.
Miotto E; Salvatore Freitas KM; Mori AA; Valarelli FP; Gobbi de Oliveira RC; Oliveira RC
Pain Manag; 2021 Sep; 11(5):583-593. PubMed ID: 33980033
[No Abstract] [Full Text] [Related]
2. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder.
Villa S; Raoul G; Machuron F; Ferri J; Nicot R
J Stomatol Oral Maxillofac Surg; 2019 Feb; 120(1):2-6. PubMed ID: 30385428
[TBL] [Abstract][Full Text] [Related]
3. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison.
Hosgor H; Coskunses FM; Altindis S
J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Efficacy of Botulinum Toxin, Local Anesthesia, and Platelet-Rich Plasma Injections in Patients With Myofascial Trigger Points in the Masseter Muscle.
Yilmaz O; Sivrikaya EC; Taskesen F; Pirpir C; Ciftci S
J Oral Maxillofac Surg; 2021 Jan; 79(1):88.e1-88.e9. PubMed ID: 33045182
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
Baker JS; Nolan PJ
J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
[TBL] [Abstract][Full Text] [Related]
9. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
[TBL] [Abstract][Full Text] [Related]
10. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
Thomas NJ; Aronovich S
J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
[TBL] [Abstract][Full Text] [Related]
11. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
Lang AM
Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
[TBL] [Abstract][Full Text] [Related]
12. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
Porta M
Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
[TBL] [Abstract][Full Text] [Related]
13. An update on botulinum toxin A injections of trigger points for myofascial pain.
Zhou JY; Wang D
Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
[TBL] [Abstract][Full Text] [Related]
14. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of occlusal splint and botulinum toxin therapies in patients with temporomandibular disorders with sleep bruxism.
Hosgor H; Altindis S; Sen E
J Orofac Orthop; 2024 May; 85(Suppl 1):102-108. PubMed ID: 37843582
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin infiltrations versus local anaesthetic infiltrations in pelvic floor myofascial pain: Multicentre, randomized, double-blind study.
Levesque A; Ploteau S; Michel F; Siproudhis L; Bautrant E; Eggermont J; Rabischong B; Volteau C; Perrouin-Verbe MA; Labat JJ
Ann Phys Rehabil Med; 2021 Jan; 64(1):101354. PubMed ID: 31981833
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
[TBL] [Abstract][Full Text] [Related]
19. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
Zhang LD; Liu Q; Zou DR; Yu LF
Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
Wheeler AH; Goolkasian P; Gretz SS
Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]